MedPath

endometrial preparation with estradiol and letrozol in IVF cycles

Phase 3
Completed
Conditions
Infertility.
Female infertility
Registration Number
IRCT20240521061861N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
178
Inclusion Criteria

Women aged 18 to 42 with frozen embryos

Exclusion Criteria

Mother's underlying disease such as thrombophilia, uncontrolled diabetes, uncontrolled hyperprolactinemia, uncontrolled thyroid disorder.
Lack of informed consent to participate in the study
Hydrosalpinx
Having uterine anomaly and premature ovarian insufficiency (POF) and low quality embryos
Repeated implantation failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.